Skip to main content
Caplight Logo









Cayuga Biotech

Cayuga Biotech

Private
New York City, New YorkHealthcare & Life Scienceshttps://cayugabiotech.com/

Last Round

Seed

Dec 11, 2025

Est. Valuation

$3.13M

Total Funding Raised

$8.74M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cayuga Biotech is a biotechnology company that develops novel therapeutics to address life-threatening hemorrhage and bleeding disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

hemostatic agentbiopharmaceuticalhemorrhage treatmentclotting therapynanoparticle therapeuticstrauma medicinebleeding disordershemostasiscombat casualty carebiomimetic materialspolyphosphate technologyclotting drugbattlefield medicineclinical-stage biotechdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cayuga Biotech Comparables

Compare Cayuga Biotech with similar companies based on industry and business-model similarity.

Cayuga Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Haima Therapeutics
87%
RxMP Therapeutics, Inc.
86%
Coagulant Therapeutics Corporation
79%

Cayuga Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025
AcceleratorJun 2, 2020
AcceleratorMay 1, 2020
GrantOct 16, 2019

Cayuga Biotech Investors

Notable investors and investment history

Cayuga Biotech investors
InvestorRounds
TBD AngelsSeed
Defense Health AgencyGrant
Wharton Alumni AngelsSeed
Walnut VenturesSeed
IndieBioAccelerator
New York VenturesSeed
Purchase CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 217% MoM.

  • Dec 11, 2025

    $5M round led by Wharton Alumni Angels

Cayuga Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cayuga Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cayuga Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2015
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?